The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Yaltormin SR 1000mg Prolonged Release Tablets

1000 milligram(s) Prolonged-release tablet

Wockhardt UK LimitedPA1339/063/003

Main Information

Trade NameYaltormin SR 1000mg Prolonged Release Tablets
Active SubstancesMETFORMIN HYDROCHLORIDE
Strength1000 milligram(s)
Dosage FormProlonged-release tablet
Licence HolderWockhardt UK Limited
Licence NumberPA1339/063/003

Group Information

ATC CodeA10BA Biguanides
A10BA02 metformin

Status

Authorised/WithdrawnAuthorised
Licence Issued08/04/2016
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back